arginine has been researched along with Coxsackie Virus Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiraoka, Y; Kishimoto, C; Ochiai, H; Takada, H | 1 |
| Collins, DN; Ramsingh, AI | 1 |
| Allen, G; Herskowitz, A; Hill, SL; Lafond-Walker, A; Landavere, M; Lowenstein, CJ; Rose, NR; Wu, J | 1 |
3 other study(ies) available for arginine and Coxsackie Virus Infections
| Article | Year |
|---|---|
Oral L-arginine prevents murine coxsackievirus B3 myocarditis.
Topics: Administration, Oral; Animals; Arginine; Coxsackievirus Infections; Disease Models, Animal; Enterovirus B, Human; Enzyme Inhibitors; Male; Mice; Mice, Inbred C3H; Myocarditis; NG-Nitroarginine Methyl Ester; Severity of Illness Index; Survival Rate | 2002 |
A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence.
Topics: Amino Acid Sequence; Amylases; Animals; Arginine; Capsid; Capsid Proteins; Chimera; Coxsackievirus Infections; Enterovirus B, Human; Genotype; Mice; Pancreas; Phenotype; Point Mutation; Restriction Mapping; Serine; Viral Plaque Assay; Virulence | 1995 |
Nitric oxide inhibits viral replication in murine myocarditis.
Topics: Amino Acid Sequence; Animals; Antibodies; Arginine; Cell Line; Cells, Cultured; Coxsackievirus Infections; Enterovirus B, Human; Enzyme Induction; Enzyme Inhibitors; Immunohistochemistry; Isoenzymes; Macrophage Activation; Macrophages; Mice; Mice, Inbred Strains; Molecular Sequence Data; Myocarditis; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Peptide Fragments; Rabbits; Spleen; Transcription, Genetic; Virus Replication | 1996 |